Skip to main content

Specialist support at the point where trials lose time.

Rif Research works at study start-up: feasibility, site selection, site activation, clinical trial applications and the regulatory groundwork that determines whether a study opens on schedule or slips a quarter.

01

Study start-up acceleration.

Country and site feasibility, activation planning, bottleneck analysis and delivery oversight from first site selected to first participant in.

Founder track record: first participant in within 8 weeks on accelerated vaccine programmes.

Typical deliverables

feasibility plan, activation forecast, critical path map.

02

Regulatory submissions and readiness.

Clinical trial applications across the UK, Ireland and other EU Member States. UK: combined MHRA and research ethics committee review under the reformed UK regulations. EU: submission strategy via CTIS under the EU CTR, including Part I and Part II dossier governance, substantial modifications and RFI response management. In Ireland, the HPRA and NREC-CT assess applications submitted through CTIS.

Founder track record: strategic oversight of Irish EU CTR submissions through CTIS, assessed by the HPRA and NREC-CT, accountable for submission strategy, risk identification and mitigation planning.

Typical deliverables

submission strategy, country sequencing, document checklist, submission tracker.

03

Start-up rescue and delivery advisory.

When activation timelines drift, we find the cause, reset the critical path and restore sponsor confidence. We also provide risk-based governance, vendor oversight and start-up process design for sponsors building or rebuilding capability.

Founder track record: a multi-country programme recovered from severely delayed start-up timelines.

Typical deliverables

root cause review, reset critical path, recovery plan, governance framework, vendor oversight plan.

04

Quality risk management and inspection readiness.

Risk identification, assessment and mitigation across studies, countries, vendors and sites, in line with ICH E6(R3). Risk registers, escalation pathways, centralised monitoring review, CAPA delivery and inspection preparation, so your teams see risks early and act before they reach the critical path.

Founder track record: start-up subject matter expert through an MHRA inspection, with CAPA delivery at country and study level.

Typical deliverables

risk register, escalation pathway, CAPA plan, inspection readiness review.

Discuss your study

Not sure where your timeline is slipping? We review your start-up plan, identify the bottlenecks and deliver a written recovery plan with clear owners and dates.

Ask about the diagnostic

Ways of working

start-up diagnostic; project engagement, including training workshops; and fractional start-up leadership, as an advisory retainer or interim leadership.